Alkermes PLC | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
362
631
535
497
434
539
Total Accounts Receivable
134
152
155
191
234
300
Inventories
46
51
38
63
93
90
Other Current Assets
28
43
26
39
48
53
Total Current Assets
570
877
755
790
809
983
Net Property, Plant & Equipment
274
266
255
265
285
310
Total Investments and Advances
90
172
266
122
157
86
Intangible Assets
630
574
472
411
349
284
Other Assets
13
33
68
90
99
76
Total Assets
1,578
1,921
1,856
1,726
1,797
1,825
ST Debt & Current Portion LT Debt
7
7
66
3
3
Accounts Payable
19
32
37
46
56
Income Tax Payable
-
-
-
1
-
Other Current Liabilities
75
91
133
162
233
Total Current Liabilities
101
131
236
212
291
Long-Term Debt
358
351
284
281
278
Deferred Taxes
29
19
40
48
99
Other Liabilities
25
24
21
24
25
Total Liabilities
512
524
541
517
594
Common Equity (Total)
1,065
1,397
1,314
1,209
1,203
Total Shareholders' Equity
1,065
1,397
1,314
1,209
1,203
Total Equity
1,065
1,397
1,314
1,209
1,203
Liabilities & Shareholders' Equity
1,578
1,921
1,856
1,726
1,797

About Alkermes

View Profile
Address
Connaught House
Dublin Dublin D04 C5Y6
Ireland
Employees -
Website http://www.alkermes.com
Updated 07/08/2019
Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U. S.